Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Short-Term Debt issuances (2018 - 2019)

Health Catalyst (HCAT) has disclosed Short-Term Debt issuances for 2 consecutive years, with $47.2 million as the latest value for Q1 2019.

  • For the quarter ending Q1 2019, Short-Term Debt issuances changed N/A year-over-year to $47.2 million, compared with a TTM value of $47.2 million through Dec 2019, changed N/A, and an annual FY2019 reading of $47.2 million, up 374.06% over the prior year.
  • Short-Term Debt issuances was $47.2 million for Q1 2019 at Health Catalyst, up from $10.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $47.2 million in Q1 2019 and bottomed at $10.0 million in Q4 2018.